# Volatile Organic Compounds for the Assessment of Liver Disease

> **NCT04620538** · — · COMPLETED · sponsor: **Imperial College London** · enrollment: 56 (actual)

## Conditions studied

- Cirrhosis
- Cirrhosis, Liver
- Fibrosis, Liver
- Hepatocellular Carcinoma
- Hepatocellular Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Breath Analysis

## Key facts

- **NCT ID:** NCT04620538
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2026-03-25
- **Final completion:** 2026-03-26
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04620538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04620538, "Volatile Organic Compounds for the Assessment of Liver Disease". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT04620538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*